Metformin Hydrochloride Lyrus

Metformin Hydrochloride, the active ingredient in Metformin Hydrochloride Lyrus, is a biguanide presented as an oral tablet for oral use. It is used to improve blood glucose control in adults with type 2 diabetes mellitus and to manage metabolic aspects of polycystic ovary syndrome.

GNH USA supplies Metformin Hydrochloride Lyrus as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metformin Hydrochloride is indicated for conditions that involve impaired glucose regulation or insulin resistance.

Type 2 diabetes mellitus: lowers fasting and post‑prandial blood glucose levels to achieve glycaemic targets. Polycystic ovary syndrome: improves insulin sensitivity, helping to restore ovulation and reduce androgen excess. Prediabetes: delays progression to overt type 2 diabetes by improving insulin action.

Metformin Hydrochloride may cause a range of adverse reactions. Most are mild and transient, but serious events can occur.

Common Side Effects: - Gastrointestinal upset: nausea, abdominal discomfort, or loss of appetite. - Diarrhea: frequent loose stools, especially during treatment initiation. - Metallic taste: transient alteration in taste perception. - Vitamin B12 deficiency: reduced absorption with long‑term use.

Serious or Rare Side Effects: - Lactic acidosis: rare but life‑threatening metabolic acidosis. - Severe skin reactions: such as Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Hepatic dysfunction: marked elevation of liver enzymes or hepatitis. - Hypoglycaemia: when combined with insulin or secretagogues. - Pancreatitis: inflammation of the pancreas.

Metformin Hydrochloride requires careful assessment of patient factors and monitoring during therapy.

Renal function: evaluate eGFR before starting and periodically thereafter. Hepatic disease: avoid use in patients with severe hepatic impairment. Lactic acidosis risk: discontinue if patient develops unexplained acidosis, hypoxia, or severe infection. Pregnancy and lactation: use only if potential benefit justifies potential risk to fetus or infant. Store at ambient temperature: keep in original container, protect from moisture and heat.

Metformin Hydrochloride can interact with several medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Iodinated contrast agents: may precipitate acute renal failure and increase lactic acidosis risk. - Alcohol: potentiates lactic acidosis, especially in chronic heavy drinkers. - Cimetidine: can raise metformin plasma concentrations.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may mask hypoglycaemia symptoms. - Diuretics and ACE inhibitors: can affect renal function, requiring dose adjustment. - NSAIDs: may reduce renal clearance of metformin. - Thyroid hormones: may alter glycaemic control, necessitating monitoring.